Suitability of Amoxicillin–Clavulanic Acid for Administration via Prolonged Infusion

摘要

Previously, we have been able to outpace bacterial mutation by replacing increasingly ineffective antibiotics with new agents. However, with the discovery of new antibiotics diminishing, optimising the administration of existing broad-spectrum antibiotics such as co-amoxiclav has become a necessity.